HBsAg Testing Market Size, Share & Industry Analysis, By Type (Qualitative and Quantitative), By Technique (Enzyme-linked immunosorbent Assay, Chemiluminescence Immunoassay, and Chromatographic Immunoassay), By Setting (Point of Care and Laboratory-based), By Sample Type (Blood, Plasma, and Others), By End-User (Hospitals & Clinics, Clinical Laboratories, and Others), and Regional Forecast, 2026-2034

ATTRIBUTE

DETAILS

Study Period

2021-2034

Base Year

2025

Estimated Year

2026

Forecast Period

2026-2034

Historical Period

2021-2024

Growth Rate

CAGR of 6.07% from 2026-2034

Unit

Value (USD Billion)

Segmentation

By Type

• Qualitative
• Quantitative

By Technique

• Enzyme-linked immunosorbent Assay
• Chemiluminescence Immunoassay
• Chromatographic Immunoassay

By Setting

• Point of Care
• Laboratory-based

By Sample Type

• Blood
• Plasma
• Others

By End-user

• Hospitals & Clinics
• Clinical Laboratories
• Others

By Region

• North America (By Type, Technique, Setting, Sample Type, End-user, and Country)
  • U.S.
  • Canada
• Europe (By Type, Technique, Setting, Sample Type, End-user, and Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Sweden
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Type, Technique, Setting, Sample Type, End-user, and Country/Sub-region)
  • Japan
  • China
  • Australia
  • India
  • New Zealand
  • Taiwan
  • South Korea
  • Singapore
  • Hong Kong
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Type, Technique, Setting, Sample Type, End-user, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, Technique, Setting, Sample Type, End-user, and Country/Sub-region)
  • South Africa
  • GCC
  • Rest of the Middle East & Africa